CSL’s new brand positioning is actually its first—and it comes after more than 100 years in business. CSL, the parent of biotherapy maker CSL Behring and its flu vaccine division Seqirus, was originally founded as a government agency in Australia in 1916 to source therapies for the then-isolated island country. But CSL has since come a long way.Original Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.